Agomab Therapeutics

Developer of monoclonal antibody molecules for multiple disorders

placeGhent, Flanders, Belgium calendar_todayFounded 2017 groups23 employees language agomab.com

Registered entities

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing.

Social engagement

Social engagement: 11.8K social following, 9 posts in the last 12 months — below the industry typical range.

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

11 Jun 2026 · IFRS & Reporting Manager

Based on job postings tracked across public sources.

Recent activity

15 Jun 2026
Event
Scaling to and Through the U.S.: Capital Pathways for European Companies panel discussion
10 Jun 2026
Event
J.P. Morgan European Healthcare Symposium
3 Jun 2026
Event
RCE2026 Annual Meeting of the Cerle d'Economia
Coming soon